Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 25, 2017 - Issue 3
Submit an article Journal homepage
337
Views
11
CrossRef citations to date
0
Altmetric
Articles

Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis

Alireza HedayatfarNoor Ophthalmic Research Center, Noor Eye Hospital, Tehran, Iran;Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
, MD,
Khalil Ghasemi FalavarjaniEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD,
Masoud SoheilianOphthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti Medical University, Tehran, Iran
, MD,
Navid Elmi SadrEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD,
Mehdi ModarresEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD,
Mohammad Mehdi ParvareshEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD,
Masood NaseripourEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD,
Mohammad RohaniDepartment of Neurology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD,
Mostafa AlmasiDepartment of Neurology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
, MD &
Soon-Phaik CheeSingapore National Eye Centre, Singapore;Singapore Eye Research Institute, Singapore;Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;Duke-NUS Graduate Medical School, Singapore
, FRCS(G), FRCOphth(UK) show all
Pages 308-314 | Received 11 Aug 2015, Accepted 06 Apr 2016, Published online: 05 Jul 2016

REFERENCES

  • Gordon LK, Goldstein DA. Gender and uveitis in patients with multiple sclerosis. J Ophthalmol. 2014;2014:565262.
  • Messenger W, Hildebrandt L, Mackensen F, et al. Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol. 2015;99:205–209.
  • Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12:137–142.
  • Le Scanff J, Sève P, Renoux C, et al. Uveitis associated with multiple sclerosis. Multiple Sclerosis. 2008;14:415–417.
  • Kieseier BC, Wiendl H, Leussink VI, et al. Immunomodulatory treatment strategies in multiple sclerosis. J Neurol. 2008;255:15–21.
  • Gauthier SA, Buckle GJ, Weiner HL. Immunosuppressive therapy for multiple sclerosis. Neurol Clin. 2005;23:247–272.
  • Stankiewicz JM, Kolb H, Karni A, et al. Role of immunosuppressive therapy for the treatment of multiple sclerosis. Neurotherapeutics. 2013;10:77–88.
  • Ahrens N, Salama A, Haas J. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. J Neurol. 2001;248:713–714.
  • Frohman EM, Brannon K, Racke MK, et al. Mycophenolate mofetil in multiple sclerosis. Clin Neuropharmacol. 2004;27:80–83.
  • Rathinam SR, Babu M, Thundikandy R, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014;121:1863–1870.
  • Gafson A, Giovannoni G, Hawkes CH. The diagnostic criteria for multiple sclerosis: from Charcot to McDonald. Mult Scler Relat Disord. 2012;1:9–14.
  • Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Michel L, Vukusic S, De Seze J, et al. Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients. J Neurol Neurosurg Psychiatry. 2014;85:279–283.
  • Pandit L, Mustafa S, Malli C, et al. Mycophenolate mofetil in the treatment of multiple sclerosis: a preliminary report. Neurol India. 2014;62:646–648.
  • Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center – analysis of 1916 patients. J Rheumatol. 2009;36:127–136.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.